Clinical Trials Directory

Trials / Conditions / Smoldering Plasma Cell Myeloma

Smoldering Plasma Cell Myeloma

14 registered clinical trials studyying Smoldering Plasma Cell Myeloma — 5 currently recruiting.

StatusTrialSponsorPhase
RecruitingNon-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With
NCT05312255
Roswell Park Cancer InstituteN/A
TerminatedImmunomodulatory Drugs (Lenalidomide With or Without Pomalidomide) in Combination With a Corticosteroid Drug (
NCT05288062
Mayo ClinicPhase 2
Active Not RecruitingLeflunomide for the Treatment of High-Risk Smoldering Multiple Myeloma in African-American and European-Americ
NCT05014646
City of Hope Medical CenterPhase 2
RecruitingIberdomide Alone or in Combination With Dexamethasone for the Treatment of Intermediate- or High-Risk Smolderi
NCT04776395
Emory UniversityPhase 2
Active Not RecruitingLeflunomide for the Treatment of High-Risk Smoldering Multiple Myeloma
NCT04370483
City of Hope Medical CenterEARLY_Phase 1
WithdrawnLeflunomide in Treating Patients With High-Risk Smoldering Multiple Myeloma
NCT03952832
City of Hope Medical CenterPhase 2
RecruitingLenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Mye
NCT03937635
ECOG-ACRIN Cancer Research GroupPhase 3
CompletedPersonalized Vaccine in Treating Patients With Smoldering Multiple Myeloma
NCT03631043
M.D. Anderson Cancer CenterEARLY_Phase 1
Active Not RecruitingIsatuximab With or Without Lenalidomide in Patients With High Risk Smoldering Multiple Myeloma (ISAMAR)
NCT02960555
M.D. Anderson Cancer CenterPhase 2
Active Not RecruitingPembrolizumab in Treating Patients With Intermediate or High-Risk Smoldering Multiple Myeloma
NCT02603887
M.D. Anderson Cancer CenterEARLY_Phase 1
RecruitingQuality of Life in Patients With Asymptomatic Monoclonal Gammopathies
NCT05136807
M.D. Anderson Cancer Center—
CompletedLenalidomide and Dexamethasone With or Without Anakinra in Treating Patients With Early Stage Multiple Myeloma
NCT02492750
Mayo ClinicPhase 1
RecruitingObservational Prospective Research Study In Monoclonal Gammopathies leadINg to Myeloma
NCT02726750
M.D. Anderson Cancer Center—
TerminatedMelphalan and Bortezomib Prior to Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma
NCT02353572
University of Colorado, DenverPhase 1 / Phase 2